Mirum Pharmaceuticals’ MIRM lead product, Livmarli (maralixibat), an orally administered ileal bile acid transporter (“IBAT”) ...

Bile duct inflammation and scarring, known as cholangiopathies, can disrupt bile flow, leading to liver damage and ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of ...

A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.

H.C. Wainwright raised the firm’s price target on ProQR Therapeutics (PRQR) to $12 from $10 and keeps a Buy rating on the shares. The firm says ...

NorUDCA (24-nor-ursodeoxycholic acid) is a chemically modified bile acid that has already shown promising results in the ...

Explore the causes of itching in liver diseases and tips to relieve discomfort. Learn about treatments for pruritus and when ...

Objective Most prognostic models for primary sclerosing cholangitis (PSC) are based on patients referred to tertiary care and may not be applicable for the majority of patients with PSC. The aim of ...

1 Translational Research Center for Gastrointestinal Disorders (TARGID), University of Leuven, Leuven, Belgium Objective Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease ...

Bexotegrast has has received fast track and orphan drug tags from the FDA in IPF and primary sclerosing cholangitis (PSC), and is Pliant’s most clinically advanced asset. Since the ...

François-Philippe Champagne, Minister of Innovation, Science and Industry "We are grateful for how the Conscience grant is supporting Primary Sclerosing Cholangitis (PSC) research. PSC is a rare ...